RiverGlades Family Offices’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,650	Closed	-$352K	–	84
2021 Q4	$352K	Hold	5,650	–	–	0.26%	62
2021 Q3	$334K	Hold	5,650	–	–	0.26%	58
2021 Q2	$378K	Hold	5,650	–	–	0.29%	54
2021 Q1	$357K	Sell	5,650 -150	-3%	-$9.48K	0.29%	54
2020 Q4	$360K	Sell	5,800 -1,200	-17%	-$74.5K	0.31%	52
2020 Q3	$422K	Hold	7,000	–	–	0.4%	41
2020 Q2	$412K	Sell	7,000 -300	-4%	-$17.7K	0.42%	44
2020 Q1	$407K	Hold	7,300	–	–	0.43%	39
2019 Q4	$469K	Sell	7,300 -1,000	-12%	-$64.2K	0.4%	42
2019 Q3	$421K	Hold	8,300	–	–	0.38%	43
2019 Q2	$376K	Buy	8,300 +1,100	+15%	+$49.8K	0.34%	48
2019 Q1	$344K	Buy	+7,200	New	+$344K	0.31%	50
2018 Q4	–	Sell	-6,200	Closed	-$385K	–	43
2018 Q3	$385K	Sell	6,200 -60	-1%	-$3.73K	0.33%	48
2018 Q2	$346K	Sell	6,260 -4,740	-43%	-$262K	0.3%	51
2018 Q1	$696K	Buy	11,000 +2,115	+24%	+$134K	0.55%	34
2017 Q4	$544K	Buy	+8,885	New	+$544K	0.45%	37